• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP - Case-series study: Severe illness common with MERS

Laidback Al

Well-known member
Case-series study: Severe illness common with MERS

October 9, 2014

http://www.cidrap.umn.edu/news-perspective/2014/10/news-scan-oct-09-2014


Experience gained at one Saudi Arabia institution on the clinical aspects and outcomes of 70 MERS-CoV patients found that severe illness was common, particularly in those with concomitant infections and/or low albumin levels, as were fatalities, with age 65 or over the only independent risk factor for death.

The study was released today in the International Journal of Infectious Disease.

The records of 70 consecutive lab-confirmed MERS-CoV (Middle East respiratory syndrome coronavirus) cases seen at tertiary care center Prince Sultan Military Medical City in Riyadh from Oct 1, 2012, through May 31, 2014, were examined retrospectively. Median age was 62 years, males accounted for 65.7% of the cases, and just over half (55.7%) acquired their illness in the healthcare setting.

Hospital admission was required in 64 cases (91.4%). Fever, dyspnea, and cough were the most common symptoms, occurring in 43 (61.4%), 42 (60%), and 38 (54.3%) case-patients, respectively. Pneumonia developed in 63 (90%), and 49 (70%) were treated in the intensive care unit (ICU).
Forty-nine patients (70%) required ICU admission; associated factors were concomitant infections (odds ratio [OR], 14.13; 95% confidence interval [CI] 1.58-126.09; P = 0.018) and low levels of albumin (OR, 6.31; 95% CI, 1.24-31.90; P = 0.026). Forty-two patients (60%) died in the hospital, with age over 65 years associated with mortality (OR, 4.39; 95% CI, 2.13-9.05; P < 0.0001).

Recent (within 2 weeks of illness onset) exposure to animals, including camels, was present in only 3 cases (4.3%).

The authors noted multiple healthcare-associated clusters in their cohort and note that one patient transmitted the disease to 10 others.
The first case of MERS-CoV was reported in June of 2012 in Saudi Arabia. Since that time it has caused more than 750 cases with more than 320 deaths in multiple countries.

Oct 9 Int J Infect Dis abstract
 
Back
Top Bottom